Indications
- Non-Insulin Dependent Diabetes Mellitus (NIDDM) (see Diabetes Mellitus, [[Diabetes Mellitus]])
Pharmacology
- First-Generation Sulfonylurea (see Sulfonylureas, [[Sulfonylureas]])
Administration
- xxxx
Adverse Effects
Gastrointestinal Adverse Effects
-
Asymptomatic Elevation of Hepatic Transaminases (Isolated Transaminitis) (see Drug-Induced Hepatotoxicity, [[Drug-Induced Hepatotoxicity]])
-
xxx
References
- xxxx